Abstract: A solid oxide cell includes a fuel electrode, an air electrode, and an electrolyte disposed between the fuel electrode and the air electrode. The fuel electrode includes a plurality of pore arrays arranged in a first direction. One of the plurality of pore arrays includes a plurality of pores arranged in a second direction. The first direction refers to a thickness direction of the electrolyte, and the second direction refers to a direction perpendicular to the first direction.

Abstract: A battery can include an electrode assembly having a first electrode, a second electrode and a separator. The first electrode can include a first active material region coated with an active material layer along a winding direction and a first uncoated region not coated with the active material layer, and at least part of the first uncoated region used as an electrode tab. The battery can further include a first current collector coupled to at least part of the first uncoated region on the electrode assembly, a battery housing to accommodate the electrode assembly and the first current collector, and an insulator between an inner surface of the battery housing facing the first uncoated region or the first current collector and the first uncoated region or the first current collector to block the electrical connection between the first uncoated region and the battery housing.

Abstract: A battery includes an electrode assembly including a first electrode, second electrode, and a separator between the first electrode and the second electrode, the first electrode including a first region coated with an active material and a second region at a first side and adjacent to the first region, the second region being exposed beyond the separator, and at least part of the second region is an electrode tab; a housing including a first end with a first opening, the housing accommodating the electrode assembly; a first current collector including an edge portion on the electrode assembly, a second region coupling portion extending from the edge portion and coupled with the second region, and a terminal coupling portion spaced apart from the second region coupling portion; and a terminal coupled with the terminal coupling portion.

Abstract: An electrode assembly, a battery, and a battery pack and a vehicle including the same are provided. In the electrode assembly, a first electrode, a second electrode, and a separator interposed therebetween are wound based on an axis to define a core and an outer circumference. The first electrode includes a first portion coated with an active material and a second portion at a first side and adjacent the first portion, the second portion being exposed beyond the separator along a first axial direction of the electrode assembly. A part of the second portion is bent in a radial direction of the electrode assembly forming a first surface region including stacked layers of the second portion, and in a partial region of the first surface region, a number of the stacked layers of the second portion is 10 or more in the in the first axial direction.

Abstract: A electronic device and method for providing store payment service are provided. An electronic device for providing store payment service comprising a processor; and a memory operatively coupled to the processor, wherein the memory, when executed, causes the processor to identify first tracking data of the tracking data corresponding to a first time period including the trigger time point, identify a user candidate group for at least some of the at least one user based on the first tracking data, calculate a first reliability for each of the at least some users included in the user candidate group, identify that a user related to the trigger is a first user based on the first reliability, and store instructions for performing an update related to the trigger for a virtual shopping cart of the first user.

Abstract: The present disclosure relates to a plurality of host materials comprising a compound represented by formula 1 and a compound represented by formula 2, and an organic electroluminescent device comprising the same. By comprising the plurality of host materials comprising a specific combination of compounds, it is possible to provide an organic electroluminescent device having long lifespan characteristics.

Abstract: A display device includes a substrate including a pixel region and a peripheral region. A plurality of pixels is disposed in the pixel region of the substrate. Each of the plurality of pixels includes a light emitting element. Data lines and scan lines are connected to each of the plurality of pixels. A power line is configured to supply power to the plurality of pixels. The power line includes a plurality of first conductive lines and a plurality of second conductive lines intersecting the plurality of first conductive lines. The plurality of second conductive lines is arranged in a region between adjacent light emitting elements of the plurality of pixels. At least some of the plurality of second conductive lines extend in a direction oblique to a direction of extension of the data lines or the scan lines.

Abstract: The present disclosure relates to an organic light emitting diode including a first electrode; a second electrode facing the first electrode; and a first emitting part including a first blue emitting layer, a second blue emitting layer, an electron transporting layer and positioned between the first and second electrode, wherein the first blue emitting layer includes a first host and a first dopant, and the second blue emitting layer includes a second host and a second dopant, wherein the first host is an anthracene derivative having a first deuteration ratio, and the second host is an anthracene derivative having a second deuteration ratio smaller than the first deuteration ratio, wherein the first dopant is a first compound represented by Formula 3, and wherein the first electron transporting layer includes an electron transporting material represented by Formula 9.

Abstract: The present invention relates to an organic light emitting diode including first and second electrodes facing each other; and a first emitting part including a first blue emitting layer, a second blue emitting layer, an electron transporting layer and positioned between the first and second electrode, wherein the first blue emitting layer includes a first host and a first dopant, and the second blue emitting layer includes a second host and a second dopant, wherein the first host is an anthracene derivative having a first deuteration ratio, and the second host is an anthracene derivative having a second deuteration ratio smaller than the first deuteration ratio, wherein the first dopant is a first compound represented by Formula 3, and wherein the first electron transporting layer includes at least one of a first electron transporting material represented by Formula 9 and a second electron transporting material represented by Formula 10.

Abstract: The present disclosure provides an intraoral fast disintegrating formulation containing hemp oil extract or hemp powder extract as a raw material of the formulation, wherein the formulation contains a water-soluble binder, an inorganic material and a surfactant.

Abstract: The present disclosure relates to an orally administered pharmaceutical formulation containing an inclusion complex formed as varenicline or a pharmaceutically acceptable salt thereof is included in cyclodextrin. The pharmaceutical formulation can improve convenience of medication by effectively masking the bitter taste of the drug and the irritation during swallowing, can provide the oxidation stability of varenicline and can improve the solubility of the drug.

Abstract: The present disclosure relates to a film formulation for oral administration, containing tadalafil free base and a method of preparing the same, and a film may be provided with maximized dispersion stability of tadalafil free base in the film by the addition of a dispersion stabilizing agent in small amounts without unique fragrance or favor that may appear when other dispersion stabilizing agents known in the art are used, and an extremely low likelihood that a reagglomeration phenomenon of tadalafil free base particles will occur, and an amount of bubbles generated may be significantly reduced during a production process.

Abstract: The present disclosure relates to a film formulation for oral administration, containing tadalafil free base and a method of preparing the same, and a film may be provided with maximized dispersion stability of tadalafil free base in the film by the addition of a dispersion stabilizing agent in small amounts without unique fragrance or favor that may appear when other dispersion stabilizing agents known in the art are used, and an extremely low likelihood that a reagglomeration phenomenon of tadalafil free base particles will occur, and an amount of bubbles generated may be significantly reduced during a production process.

Abstract: The present disclosure relates to a pharmaceutical preparation having varenicline or a pharmaceutically acceptable salt thereof as an active ingredient. More particularly, it relates to an orally administered pharmaceutical preparation which allows limited use of a sweetening agent or a flavoring agent by effectively masking the unique taste of varenicline, particularly bitterness, which is a bitter and burning taste, and ensures convenience in taking the pharmaceutical preparation by being orally administrable without irritation, while containing a pharmaceutically effective amount of varenicline or a pharmaceutically acceptable salt thereof, and a method for preparing the same.

Abstract: The present disclosure relates to a film formulation for oral administration, containing tadalafil free base and a method of preparing the same, and a film may be provided with maximized dispersion stability of tadalafil free base in the film by the addition of a dispersion stabilizing agent in small amounts without unique fragrance or favor that may appear when other dispersion stabilizing agents known in the art are used, and an extremely low likelihood that a reagglomeration phenomenon of tadalafil free base particles will occur, and an amount of bubbles generated may be significantly reduced during a production process.

Abstract: The present disclosure relates to an orally administered pharmaceutical formulation containing an inclusion complex formed as varenicline or a pharmaceutically acceptable salt thereof is included in cyclodextrin. The pharmaceutical formulation can improve convenience of medication by effectively masking the bitter taste of the drug and the irritation during swallowing, can provide the oxidation stability of varenicline and can improve the solubility of the drug.

Abstract: A battery pack includes a first battery with a first capacity, a second battery with a second capacity less than the first capacity, and a variable resistor. The second battery has a larger maximum discharge current than the first battery. The variable resistor circuit limits the discharge current of the first battery to a predetermined limit current value.

Abstract: The present invention relates to a pharmaceutical preparation for oral administration comprising, as an active ingredient, clomipramine or a pharmaceutically acceptable salt thereof; and a cation exchange resin and an anion polymer as a taste masking agent, wherein the pharmaceutical preparation can be orally administered even while comprising a pharmaceutically effective amount of clomipramine because the unique tastes of clomipramine, particularly, all of the bitter taste, spicy taste and burning taste are effectively masked, and thus the convenience of drug intake and portability is improved, and a method for manufacturing thereof.

Abstract: The present invention relates to a pharmaceutical preparation comprising entecavir as an active ingredient, wherein an antioxidizing agent is added to enhance stability of entecavir, and a method for preparing the same. According to the present invention, the invention has an effect that entecavir can be stably maintained in a pharmaceutical preparation containing a certain amount or more of moisture by adding the antioxidizing agent, thereby a pharmaceutical preparation can be provided as a formulation containing a certain amount or more of moisture, for example, an orally disintegrating film formulation.

Abstract: The present invention provides a method for preparing a film comprising a high amount of a sildenafil free base uniformly dispersed therein and having a suitable thickness and size, as well as flexibility providing good handling stability and being not prone to breaking. The present invention also provides a sildenafil free base-containing film prepared from the method.